About viral hepatitis and retrovirus diagnostic tests
Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patients without having a direct therapeutic effect. Hence, they play a significant role in supporting decision-making in clinical conditions. Advances in diagnostic testing systems and assays have led to the development of self-testing, which are easy to perform and convenient for both medical professionals and patients. The diagnostic tests for viral hepatitis and retrovirus can be carried out in hospitals, clinics, or at home.
Technavio's analysts forecast the global viral hepatitis and retrovirus diagnostic tests market to grow at a CAGR of 10.83% over the period 2014-2019.
Covered in this report
The report covers the current scenario and the growth prospects of the global viral hepatitis and retrovirus diagnostic tests market for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of assays and instruments for diagnostic testing of viral hepatitis and retrovirus.
Technavio's report, Global Viral Hepatitis and Retrovirus Diagnostic Tests Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
• APAC
• Europe
• Latin America
• MEA
• North America
Key vendors
• Abbott Diagnostics
• Alere
• Chembio
• DiaSorin
• Roche Diagnostics
Other prominent vendors
• Amkay Products
• AOV International
• Apothecaries Sundries Manufacturing
• Beckman Coulter
• Becton Dickinson
• Bhat Bio-tech
• bioMerieux
• Bioneovan
• Bio-Rad
• Cepheid
• Enzo Biochem
• Fujirebio
• Gemc Technology (Zhengzhou)
• Grifols
• Hangzhou Deangel Biological Engineering
• Hangzhou Heo Bio-Tech
• Hologic
• Horiba
• Innovation Biotech (Beijing)
• Jaksh Enterprises
• Krishco Medical Products
• Micro Sidd
• Nantong Egens Biotechnology
• Nexus Lifecare
• Ortho-Clinical Diagnostics
• Qiagen
• Qingdao Hightop Biotech
• Scienion
• SeraCare
• Shanghai Kehua Bio-engineering
• Siemens Healthcare Diagnostics
• Span Diagnostics
• Synergy Healthcare
• Thermo Fisher Scientific
• Transasia Bio-Medicals
• Wako
• YVR Medivision
• Zhuhai Encode Medical Engineering
Market driver
• High prevalence and awareness of HIV and hepatitis
• For a full, detailed list, view our report
Market challenge
• Limitation of closed system
• For a full, detailed list, view our report
Market trend
• Increased usage of POC diagnostic tests
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Overview
Hepatitis
HIV
PART 06: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 07: Geographical segmentation
Global viral hepatitis and retrovirus diagnostic tests market by geographical segmentation
Viral hepatitis and retrovirus diagnostic tests market in Americas
Viral hepatitis and retrovirus diagnostic tests market in EMEA
Viral hepatitis and retrovirus diagnostic tests market in APAC
PART 08: Key focus countries
Brazil
China
PART 09: Market drivers
PART 10: Impact of drivers
PART 11: Market challenges
PART 12: Impact of drivers and challenges
PART 13: Market trends
PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors
PART 15: Key vendor analysis
Abbott Diagnostics
Alere
Chembio
DiaSorin
Roche Diagnostics
PART 16: Appendix
List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global endemicity of hepatitis A infection
Exhibit 03: Endemicity pattern of hepatitis B across different regions
Exhibit 04: Prevalence rates of hepatitis B in APAC
Exhibit 05: Acute hepatitis B infection by age groups (2005-2013)
Exhibit 06: Chronic hepatitis B infection by age groups (2005-2013)
Exhibit 07: Prevalence of hepatitis B in US (2005-2013)
Exhibit 08: Prevalence rates of hepatitis C across different geographies (2012)
Exhibit 09: Prevalence data of hepatitis C in APAC
Exhibit 10: Prevalence data of hepatitis C in Europe
Exhibit 11: Prevalence data of hepatitis C in Caribbean and Latin America
Exhibit 12: Prevalence data of hepatitis C in Middle-East and North Africa
Exhibit 13: Prevalence data of hepatitis C in North America
Exhibit 14: Prevalence data of hepatitis C in Sub-Saharan Africa
Exhibit 15: Medical cost for chronic viral hepatitis
Exhibit 16: Medical cost for treatment of hepatitis C-related infections
Exhibit 17: Demographic statistics for HIV (2014)
Exhibit 18: Low-cost portable tests for HIV diagnosis
Exhibit 19: Top 10 countries with highest number of healthcare facilities providing HIV testing in 2013
Exhibit 20: Global viral hepatitis and retrovirus diagnostic tests market
Exhibit 21: Global viral hepatitis and retrovirus diagnostic tests market 2014-2019 ($ millions)
Exhibit 22: Five forces analysis
Exhibit 23: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014
Exhibit 24: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2019
Exhibit 25: Segmentation of global viral hepatitis and retrovirus diagnostic tests market by geography 2014-2019
Exhibit 26: Viral hepatitis and retrovirus diagnostic tests market in Americas 2014-2019 ($ millions)
Exhibit 27: Viral hepatitis and retrovirus diagnostic tests market in EMEA 2014-2019 ($ millions)
Exhibit 28: Top countries in APAC with highest number of HIV patients (2012)
Exhibit 29: Viral hepatitis and retrovirus diagnostic tests market in APAC 2014-2019 ($ millions)
Exhibit 30: Viral hepatitis and retrovirus diagnostic tests market in Brazil 2014-2019 ($ millions)
Exhibit 31: Viral hepatitis and retrovirus diagnostic tests market in China 2014-2019 ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Abbott Diagnostics: Key takeaways
Exhibit 35: Alere: Key takeaways
Exhibit 36: Chembio: Key takeaways
Exhibit 37: DiaSorin: Key takeaways
Exhibit 38: Roche Diagnostics: Key takeaways
Exhibit 39: Abbott Diagnostics: Key business offerings
Exhibit 40: Alere: Business segmentation by revenue 2014
Exhibit 41: Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 42: Alere: Geographical segmentation comparison by revenue 2013 and 2014 ($ millions)
Exhibit 43: Chembio: Business segmentation by revenue 2014
Exhibit 44: Chembio: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 45: Chembio: Geographical segmentation by revenue 2014
Exhibit 46: DiaSorin: Business segmentation by revenue 2013 and 2014
Exhibit 47: DiaSorin: Geographical segmentation by revenue 2014
